) --




) hit a new 52-week high Monday as it is currently trading at $38.48, above its previous 52-week high of $38.46 with 1.4 million shares traded as of 2:07 p.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Sanofi-Aventis has a market cap of $99.2 billion and is part of the

health care

sector and


industry. Shares are up 14.6% year to date as of the close of trading on Thursday.

TheStreet Recommends

Sanofi-Aventis, a healthcare company, engages in the discovery, development, and distribution of therapeutic solutions to improve the lives of everyone. The company has a P/E ratio of 20.4, above the average drugs industry P/E ratio of 13.6 and above the S&P 500 P/E ratio of 16.7.

  • Practice your SNY trading strategies and win cash in our stock game.

TheStreet Ratings rates Sanofi-Aventis as a


. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Sanofi-Aventis Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center